Likewise, tumor cells and tumor-infiltrating macrophages (TAMs) produce the chemokine CCL22, which attracts regulatory T cells (Tregs) to create an immune-suppressive microenvironment, thereby impairing anticancer immunity (Martinenaite et al., 2016). This evidence concerns the gene CCL22 and neoplasm.